{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:15:42Z","timestamp":1792178142157,"version":"4.4.0"},"reference-count":48,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.3892\/or.2015.3727","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T06:41:33Z","timestamp":1421304093000},"page":"1533-1539","source":"Crossref","is-referenced-by-count":50,"title":["Epigallocatechin gallate inhibits human tongue carcinoma cells via HK2-mediated glycolysis"],"prefix":"10.3892","volume":"33","author":[{"given":"FENG","family":"GAO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MING","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEN-BIN","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHONG-SU","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RUI","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JUN-LING","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KE-CHAO","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,1,15]]},"reference":[{"key":"key20180107212807_b1-or-33-03-1533","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/10408399709527801","article-title":"Inhibition of carcinogenesis by tea: the evidence from experimental studies","volume":"37","author":"Dreosti","year":"1997","journal-title":"Crit Rev Food Sci Nutr"},{"key":"key20180107212807_b2-or-33-03-1533","first-page":"221","article-title":"Tea in chemoprevention of cancer","volume":"8","author":"Katiyar","year":"1996","journal-title":"Int J Oncol"},{"key":"key20180107212807_b3-or-33-03-1533","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev.pharmtox.42.082101.154309","article-title":"Inhibition of carcinogenesis by tea","volume":"42","author":"Yang","year":"2002","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"key20180107212807_b4-or-33-03-1533","first-page":"1307","article-title":"Green tea polyphenolic antioxidants and skin photoprotection (Review)","volume":"18","author":"Katiyar","year":"2001","journal-title":"Int J Oncol"},{"key":"key20180107212807_b5-or-33-03-1533","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/38154","article-title":"Inhibition of carcinogenesis by tea","volume":"389","author":"Yang","year":"1997","journal-title":"Nature"},{"key":"key20180107212807_b6-or-33-03-1533","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/mnfr.201100036","article-title":"Mechanistic issues concerning cancer prevention by tea catechins","volume":"55","author":"Yang","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"key20180107212807_b7-or-33-03-1533","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3892\/or.2013.2933","article-title":"Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway","volume":"31","author":"Ma","year":"2014","journal-title":"Oncol Rep"},{"key":"key20180107212807_b8-or-33-03-1533","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3892\/or.2013.2925","article-title":"(\u2212)-Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer","volume":"31","author":"Maruyama","year":"2014","journal-title":"Oncol Rep"},{"key":"key20180107212807_b9-or-33-03-1533","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1158\/1940-6207.CAPR-09-0083","article-title":"Epigallocatechin 3-gallate and green tea catechins: united they work, divided they fail","volume":"2","author":"Bode","year":"2009","journal-title":"Cancer Prev Res"},{"key":"key20180107212807_b10-or-33-03-1533","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.2174\/138945012804545506","article-title":"Cancer chemoprevention with green tea catechins: from bench to bed","volume":"13","author":"Shirakami","year":"2012","journal-title":"Curr Drug Targets"},{"key":"key20180107212807_b11-or-33-03-1533","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","article-title":"Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications","volume":"82","author":"Singh","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"key20180107212807_b12-or-33-03-1533","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/ijms9061034","article-title":"Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG","volume":"9","author":"Shimizu","year":"2008","journal-title":"Int J Mol Sci"},{"key":"key20180107212807_b13-or-33-03-1533","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3892\/ijo.2013.2006","article-title":"(\u2212)-Epigallocatechin-3-gallate blocks nicotine-induced matrix metalloproteinase-9 expression and invasiveness via suppression of NF-\u03baB and AP-1 in endothelial cells","volume":"43","author":"Khoi","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180107212807_b14-or-33-03-1533","first-page":"4414","article-title":"Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (\u2212)-epigallocatechin gallate, and theaflavins","volume":"57","author":"Dong","year":"1997","journal-title":"Cancer Res"},{"key":"key20180107212807_b15-or-33-03-1533","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1158\/1940-6207.CAPR-11-0372","article-title":"Green tea gets molecular","volume":"4","author":"Rouzer","year":"2011","journal-title":"Cancer Prev Res"},{"key":"key20180107212807_b16-or-33-03-1533","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mrfmmm.2004.05.018","article-title":"Targeting signal transduction pathways by chemopreventive agents","volume":"555","author":"Bode","year":"2004","journal-title":"Mutat Res"},{"key":"key20180107212807_b17-or-33-03-1533","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/42381","article-title":"Why drinking green tea could prevent cancer","volume":"387","author":"Jankun","year":"1997","journal-title":"Nature"},{"key":"key20180107212807_b18-or-33-03-1533","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mc.20299","article-title":"Fyn is a novel target of (\u2212)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation","volume":"47","author":"He","year":"2008","journal-title":"Mol Carcinog"},{"key":"key20180107212807_b19-or-33-03-1533","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1271\/bbb.120882","article-title":"Effects of epigallocatechin-3-gallate (EGCG) on A549 lung cancer tumor growth and angiogenesis","volume":"77","author":"Sakamoto","year":"2013","journal-title":"Biosci Biotechnol Biochem"},{"key":"key20180107212807_b20-or-33-03-1533","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jnutbio.2006.08.004","article-title":"Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair","volume":"18","author":"Katiyar","year":"2007","journal-title":"J Nutr Biochem"},{"key":"key20180107212807_b21-or-33-03-1533","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.oraloncology.2009.01.004","article-title":"Oral squamous cell carcinoma overview","volume":"45","author":"Scully","year":"2009","journal-title":"Oral Oncol"},{"key":"key20180107212807_b22-or-33-03-1533","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.oraloncology.2008.05.017","article-title":"Current concepts in management of oral cancer - surgery","volume":"45","author":"Shah","year":"2009","journal-title":"Oral Oncol"},{"key":"key20180107212807_b23-or-33-03-1533","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MOO.0b013e32835e28d2","article-title":"From wide excision to a compartmental approach in tongue tumors: what is going on?","volume":"21","author":"Calabrese","year":"2013","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"key20180107212807_b24-or-33-03-1533","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0002-9610(98)00294-3","article-title":"Clinicopathological analysis of elective neck dissection for N0 neck of early oral tongue carcinoma","volume":"177","author":"Yuen","year":"1999","journal-title":"Am J Surg"},{"key":"key20180107212807_b25-or-33-03-1533","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1758-3284-3-43","article-title":"Modern surgical management of tongue carcinoma - a clinical retrospective research over a 12 years period","volume":"3","author":"Rana","year":"2011","journal-title":"Head Neck Oncol"},{"key":"key20180107212807_b26-or-33-03-1533","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0528.2008.00448.x","article-title":"Global policy for improvement of oral health in the 21st century - implications to oral health research of World Health Assembly 2007, World Health Organization","volume":"37","author":"Petersen","year":"2009","journal-title":"Community Dent Oral Epidemiol"},{"key":"key20180107212807_b27-or-33-03-1533","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hed.21754","article-title":"Early tongue carcinoma: analysis of failure","volume":"34","author":"Preis","year":"2012","journal-title":"Head Neck"},{"key":"key20180107212807_b28-or-33-03-1533","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg\u2019s contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key20180107212807_b29-or-33-03-1533","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"key20180107212807_b30-or-33-03-1533","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrc2817","article-title":"Targeting metabolic transformation for cancer therapy","volume":"10","author":"Tennant","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"key20180107212807_b31-or-33-03-1533","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrc2468","article-title":"Hypoxia, HIF1 and glucose metabolism in the solid tumour","volume":"8","author":"Denko","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"key20180107212807_b32-or-33-03-1533","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1101\/sqb.2005.70.035","article-title":"Mitochondria and cancer: Warburg addressed","volume":"70","author":"Wallace","year":"2005","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"key20180107212807_b33-or-33-03-1533","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1158\/2159-8290.CD-13-0565","article-title":"Glycolysis back in the limelight: systemic targeting of HK2 blocks tumor growth","volume":"3","author":"Ros","year":"2013","journal-title":"Cancer Discov"},{"key":"key20180107212807_b34-or-33-03-1533","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","article-title":"Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer","volume":"24","author":"Patra","year":"2013","journal-title":"Cancer Cell"},{"key":"key20180107212807_b35-or-33-03-1533","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J Exp Med"},{"key":"key20180107212807_b36-or-33-03-1533","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1158\/0008-5472.CAN-10-4158","article-title":"Transcriptional control of cellular metabolism by mTOR signaling","volume":"71","author":"Yecies","year":"2011","journal-title":"Cancer Res"},{"key":"key20180107212807_b37-or-33-03-1533","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd4204","article-title":"PI3K and cancer: lessons, challenges and opportunities","volume":"13","author":"Fruman","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107212807_b38-or-33-03-1533","first-page":"1547","article-title":"Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach","volume":"34","author":"Ribeiro","year":"2014","journal-title":"Anticancer Res"},{"key":"key20180107212807_b39-or-33-03-1533","doi-asserted-by":"crossref","first-page":"20491","DOI":"10.1073\/pnas.1206530109","article-title":"Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death","volume":"109","author":"Cheung","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107212807_b40-or-33-03-1533","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1074\/jbc.M109950200","article-title":"Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis","volume":"277","author":"Pastorino","year":"2002","journal-title":"J Biol Chem"},{"key":"key20180107212807_b41-or-33-03-1533","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.molcel.2004.11.014","article-title":"Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak","volume":"16","author":"Majewski","year":"2004","journal-title":"Mol Cell"},{"key":"key20180107212807_b42-or-33-03-1533","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1517\/14728222.2013.833607","article-title":"Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy","volume":"17","author":"Krasnov","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"key20180107212807_b43-or-33-03-1533","first-page":"3459","article-title":"Effect of tea polyphenols on growth of oral squamous carcinoma cells in vitro","volume":"20","author":"Elattar","year":"2000","journal-title":"Anticancer Res"},{"key":"key20180107212807_b44-or-33-03-1533","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.yexcr.2013.05.001","article-title":"Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism","volume":"319","author":"Moreira","year":"2013","journal-title":"Exp Cell Res"},{"key":"key20180107212807_b45-or-33-03-1533","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbrc.2008.09.128","article-title":"Epigallocatechin gallate promotes GLUT4 translocation in skeletal muscle","volume":"377","author":"Ueda","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107212807_b46-or-33-03-1533","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ygcen.2014.01.008","article-title":"Green tea (\u2212)-epigallocatechin gallate suppresses IGF-I and IGF-II stimulation of 3T3-L1 adipocyte glucose uptake via the glucose transporter 4, but not glucose transporter 1 pathway","volume":"199","author":"Ku","year":"2014","journal-title":"Gen Comp Endocrinol"},{"key":"key20180107212807_b47-or-33-03-1533","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.bjp.0705460","article-title":"Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1","volume":"140","author":"Naftalin","year":"2003","journal-title":"Br J Pharmacol"},{"key":"key20180107212807_b48-or-33-03-1533","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1309\/BTLN5WTMJ3PCNRRC","article-title":"Expression of protein tyrosine kinases in head and neck squamous cell carcinomas","volume":"124","author":"Ongkeko","year":"2005","journal-title":"Am J Clin Pathol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.3727\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T16:28:19Z","timestamp":1515342499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.3727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,15]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,1,15]]},"published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.3892\/or.2015.3727"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.3727","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,15]]}}}